Abstract
Efficacy of Novel Multimodality Pigment-Correcting Serum for Moderate to Severe Facial Hyperpigmentation, Including Melasma, in a 12-Week, Split-Face, Double-blind, Randomized Controlled Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have